NCT06391593: An ongoing trial by Alto Neuroscience
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06391593 |
|---|---|
| Title | Double-Blind, Single and Multiple Dose Study to Determine Pharmacodynamic Markers, Pharmacokinetic Parameters, and Safety of ALTO-203 in Patients With Major Depressive Disorder |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 25, 2024 |
| Completion date | April 14, 2025 |
| Required reporting date | April 14, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 23, 2026 |
| Days late | None |